Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (9 ops.)
Latest filing published 02 Aug 2024 for Aerovate Therapeutics, Inc., €18k. Read the official filing
Filing timeline
BuySaleBenjamin T. Dake
Insider track record
Disclosed buys
0
Disclosed sells
9
Signal history
Benjamin T. Dake: trading record in brief
Benjamin T. Dake discloses dealings in Jade Biosciences, Inc. to SEC (Form 4). Over a trading history stretching from 8 August 2022 to 31 July 2024, the count stands at 46 filings.
On the market, this insider has only sold: 9 sales, €675k in total. Other entries cover 37 option exercises.
On 2 August 2024 came the latest disclosure, an option exercise for €18k in Jade Biosciences, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Benjamin T. Dake
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations46 total
11,454 shares@ US$1.741.5% of flowCommon StockSEC:0001415889-24-020662:0
6,853 shares@ US$2.141.1% of flowCommon StockSEC:0001415889-24-011252:0
3,325 shares@ US$10.612.7% of flowCommon StockSEC:0001415889-24-010137:0
11,068 shares@ US$10.618.8% of flowCommon StockSEC:0001415889-24-009364:0
3,432 shares@ US$10.612.7% of flowCommon StockSEC:0001415889-24-009243:0
20,557 shares@ US$2.143.3% of flowCommon StockSEC:0001415889-24-008770:0
2,411 shares@ US$1.740.3% of flowCommon StockSEC:0001415889-23-015986:0
2,413 shares@ US$1.740.3% of flowCommon StockSEC:0001415889-23-015599:0
2,412 shares@ US$1.740.3% of flowCommon StockSEC:0001415889-23-015509:0
2,413 shares@ US$1.740.3% of flowCommon StockSEC:0001415889-23-013130:0
2,412 shares@ US$1.740.3% of flowCommon StockSEC:0001415889-23-011986:0
2,412 shares@ US$1.740.3% of flowCommon StockSEC:0001415889-23-010966:0
2,412 shares@ US$1.740.3% of flowCommon StockSEC:0001415889-23-009448:0
7,871 shares@ US$2.141.2% of flowCommon StockSEC:0001415889-23-007686:1
8,685 shares@ US$21.624113.8% of flowCommon StockSEC:0001415889-23-007686:2
1,599 shares@ US$22.73582.7% of flowCommon StockSEC:0001415889-23-007686:3
2,413 shares@ US$1.740.3% of flowCommon StockSEC:0001415889-23-007686:0
2,412 shares@ US$1.740.3% of flowCommon StockSEC:0001415889-23-006377:0
2,412 shares@ US$1.740.3% of flowCommon StockSEC:0001415889-23-004513:0
2,412 shares@ US$1.740.3% of flowCommon StockSEC:0001415889-23-002170:0
2,413 shares@ US$1.740.3% of flowCommon StockSEC:0001415889-23-000709:0
2,059 shares@ US$2.140.3% of flowCommon StockSEC:0001415889-22-012550:0
10,000 shares@ US$2.141.6% of flowCommon StockSEC:0001415889-22-012429:0
2,412 shares@ US$1.740.3% of flowCommon StockSEC:0001415889-22-012273:0
14,000 shares@ US$2.142.4% of flowCommon StockSEC:0001415889-22-011356:0
25 of 46 declarations
